Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Immunologic Deficiency Syndromes × Phenytoin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Classical hematology 1 CNS 1

Conditions

Neuroblastoma 1 Lymphoma 1 Leukemia 1 Immunologic Deficiency Syndromes 1 Anemia 1

Interventions

thymoglobulin 1 fosphenytoin 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Thiotepa 1 Phenytoin 1 Melphalan 1 Cyclophosphamide 1 Busulfan 1 Antilymphocyte Serum 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated

1 enrolled 8 charts

CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡